ACR Appropriateness Criteria® screening for pulmonary metastases.
Screening for pulmonary metastatic disease is an important step for staging a patient with a known or recently discovered malignancy. Here we present our recommendations for screening for metastatic disease based on recommendations from the literature and experiences of pulmonary radiologists. In short, chest computed tomographic (CT) screening is the most appropriate tool for evaluation of pulmonary metastasis in the majority of cases. Chest computed tomographic screening is also recommended for follow-up and to determine response to therapy. Other modalities such as chest radiography, magnetic resonance imaging, and scintigraphy will also be discussed. Please note that this study is a summary of the complete version of this topic, which is available on the ACR website at www.acr.org. Practitioners are encouraged to refer to the complete version.
Department of Diagnostic Radiology, Cleveland Clinic, Cleveland, OH, USA. mohammed10@gmail.com
Tan-Lucien H
TL
Mohammed
Aqeel
A
Chowdhry
Gautham P
GP
Reddy
Judith K
JK
Amorosa
Kathleen
K
Brown
Debra Sue
DS
Dyer
Mark E
ME
Ginsburg
Darel E
DE
Heitkamp
Jean
J
Jeudy
Jacobo
J
Kirsch
Heber
H
MacMahon
J Anthony
JA
Parker
James G
JG
Ravenel
Anthony G
AG
Saleh
Rakesh D
RD
Shah
D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D008403:Mass Screening / Q000592:standards* / Q000639:trends; D009367:Neoplasm Staging; D011871:Radiology / Q000592:standards; D012955:Societies, Medical; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography; D014481:United States